mRNA gene expression of each gene was normalized by housekeeping geneGAPDHmRNA

mRNA gene expression of each gene was normalized by housekeeping geneGAPDHmRNA. able to normalize EtOH-induced up-regulation of Nox and RANKL. BAY-1436032 In vitro experiments exhibited that EtOH directly up-regulated Nox expression in osteoblasts. Pretreatment of osteoblasts with DPI eliminated EtOH-induced RANKL promoter activity. Furthermore, EtOH induced RANKL gene expression, and RANKL promoter activation in osteoblasts was ROS-dependent. These data suggest that inhibition of Nox expression and activity may be critical for prevention of chronic EtOH-induced osteoblast-dependent bone loss. == Introduction == Although positive effects of moderate alcohol consumption on bone health have been suggested (Jonsson et al., 2007), chronic alcohol abuse and binge alcohol exposure are well recognized as major risk factors for development of osteoporotic bone loss (Turner, 2000;Sampson, 2002;Chakkalakal, 2005;Callaci et al., 2006). The molecular mechanisms whereby ethanol (EtOH) induces bone pathophysiology are not yet clearly defined, but we and others have BAY-1436032 previously exhibited that EtOH both inhibits osteoblastic bone formation (Dyer et al., 1998;Callaci et al., 2010;Chen et al., 2010;Turner et al., 2010) and stimulates osteoclastic bone resorption (Dai et al., 2000) through direct and indirect actions (Chen et al., 2006;Shankar et al., 2008;Turner et al., 2010). The effect of EtOH on bone resorption appears to be due, at least in part, to its ability to induce receptor activator of nuclear factor-B ligand (RANKL) expression in bone and bone marrow cells, resulting in stimulation of osteoclastogenesis. EtOH can disrupt vitamin D and growth hormone homeostasis and also induce a variety of cytokines, such as tumor necrosis factor (TNF), resulting in indirect actions on bone cells (Turner et al., 1988,2010;Shankar et al., 2008). The question of how EtOH directly influences osteoblastic cell differentiation remains to be clarified (Chen et al., 2010). Evidence from previous studies GDF2 in our laboratory suggests that EtOH-induced oxidative stress accelerates activation of senescence pathways in osteoblasts (Chen et al., 2009). In addition, EtOH can freely defuse into cells and induce oxidative stress and redox changes as a consequence of metabolism to acetaldehyde and acetate by the enzymes’ alcohol and acetaldehyde dehydrogenase (Chen et al., 2006). The toxic effects of EtOH on bone cells may result from intracellular generation of reactive oxygen species (ROS) (Muller et al., 2007). However, oxidative stress in bone has not yet been exhibited directly following EtOH exposure in vivo, and limited studies have been conducted on the effects of dietary antioxidants on EtOH-induced bone loss (Chen et al., 2008,2009). In general, oxidative stress is caused by an imbalance between the production of reactive oxygen and a biological system’s ability to readily detoxify ROS. In biological systems, ROS such as superoxide and hydrogen peroxide are ubiquitous signaling molecules, and their role in tissue physiology and pathophysiology has been extensively elucidated (Li and Fukagawa, 2010). Four members of the NADPH oxidase (Nox) enzyme family are important sources of ROS in many tissues: Nox1, Nox2, Nox3, and Nox4. Nox4 is usually a constitutively active Nox enzyme expressed in nonphagocytic cells, where it appears to serve as a major source of intracellular superoxide involved in redox signaling. We have previously described the expression of Nox1, Nox2, and Nox4 and up-regulation of Nox1 and Nox4 by EtOH in vitro in osteoblasts derived from bone marrow stromal cells (Chen et al., 2008). However, whether overexpression of Nox1, Nox4, or both and increased Nox-derived superoxide production BAY-1436032 in osteoblasts is usually associated with bone loss in vivo produced by either chronic EtOH feeding or other conditions, such as sex steroid deficiency or aging, remains unclear. We have hypothesized that Nox4-mediated ROS accumulation in osteoblasts or their precursors is critical for EtOH-induced bone resorption. Estradiol may have the ability to protect against EtOH-induced bone resorption in cycling female rats (Shankar et al., 2006). The protective effects of estrogens against cellular injury in endothelial cells BAY-1436032 and neurons are considered to occur through improved defense against oxidative stress (Sack et al., 1994;Arnal et al., 1996;Sudoh et al., 2001). More recently, the effects of estrogens on antioxidant defenses in bone have been recognized and investigated with greater emphasis on pathophysiology of osteoporosis (Manolagas, 2010), particularly on osteoclasts that have been shown to be activated by ROS (Lean et al., 2003). An in vivo experiment demonstrated that decreases.